Alentis Therapeutics’ $105 Million Series C Funding Round

Walder Wyss advises Alentis Therapeutics on the financing.Alentis Therapeutics has announced $105 million in Series C financing. The funding round was led by Jeito Capital together…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Pietro Martinoia

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here